Ko C, Yang P
J Transl Med. 2025; 23(1):305.
PMID: 40065368
PMC: 11895263.
DOI: 10.1186/s12967-025-06292-x.
Zhou X, Berenger E, Shi Y, Shirokova V, Kochetkova E, Becirovic T
EMBO Mol Med. 2025; .
PMID: 40055574
DOI: 10.1038/s44321-025-00210-w.
Perelli L, Zhang L, Mangiameli S, Giannese F, Mahadevan K, Peng F
Nature. 2025; .
PMID: 40044861
DOI: 10.1038/s41586-025-08671-2.
Yun H, Han G, Wee D, Chay D, Chung J, Kim J
Cancer Genomics Proteomics. 2025; 22(2):271-284.
PMID: 39993806
PMC: 11880930.
DOI: 10.21873/cgp.20501.
Lopez-Collazo E, Hurtado-Navarro L
Front Immunol. 2025; 16:1524781.
PMID: 39967663
PMC: 11832717.
DOI: 10.3389/fimmu.2025.1524781.
Novel Nucleus-Oriented Quenched Activity-Based Probes Link Cathepsin Nuclear Localization with Mitosis.
Shannon K, Weiss-Sadan T, Merquiol E, Dey G, Gilon T, Turk B
ACS Sens. 2025; 10(2):1321-1333.
PMID: 39960252
PMC: 11877631.
DOI: 10.1021/acssensors.4c03217.
Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier.
Okuyama K, Tsuchiya M, Debnath K, Islam S, Yanamoto S
Ther Adv Med Oncol. 2025; 17:17588359251317144.
PMID: 39926258
PMC: 11806477.
DOI: 10.1177/17588359251317144.
Tumor necrosis factor receptor-associated factor 5 enhances perianal fistulizing Crohn's disease through epithelial-mesenchymal transition.
Sun X, Gao H, Lu L, Wang Q, Li Y, Gu Y
Cytojournal. 2025; 21:82.
PMID: 39917000
PMC: 11801662.
DOI: 10.25259/Cytojournal_148_2024.
The clinical impact of galectin-8 in drug resistant breast cancer.
Chien Y, Wu J, Pang C, Chou R, Yu Y
J Cancer. 2025; 16(4):1296-1309.
PMID: 39895791
PMC: 11786030.
DOI: 10.7150/jca.104000.
Lessons (to be) learned from liquid biopsies: assessment of circulating cells and cell-free DNA in cancer and pregnancy-acquired microchimerism.
Bergmann L, Afflerbach A, Yuan T, Pantel K, Smit D
Semin Immunopathol. 2025; 47(1):14.
PMID: 39893314
PMC: 11787191.
DOI: 10.1007/s00281-025-01042-z.
Oleanolic acid inhibits aldo-keto reductase family 1 member B10-induced cancer stemness and avoids cisplatin-based chemotherapy resistance via the Snail signaling pathway in oral squamous cell carcinoma cell lines.
Ko H, Chou H, Hou H, Kuo W, Liu W, Yen-Ping Kuo M
J Dent Sci. 2025; 20(1):100-108.
PMID: 39873100
PMC: 11762581.
DOI: 10.1016/j.jds.2024.09.018.
HGS Promotes Tumor Growth, Whereas the Coiled-Coil Domain and Its Oligopeptide of HGS Suppress It.
Ogura K, Kawashima I, Kasahara K
Int J Mol Sci. 2025; 26(2).
PMID: 39859488
PMC: 11766344.
DOI: 10.3390/ijms26020772.
Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in -Mutated Epithelial Ovarian Cancer Cell Lines.
Gralewska P, Biegala L, Gajek A, Szymczak-Pajor I, Marczak A, Sliwinska A
Int J Mol Sci. 2025; 26(2).
PMID: 39859407
PMC: 11766100.
DOI: 10.3390/ijms26020693.
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial-Mesenchymal Transition.
Blaszczak E, Miziak P, Odrzywolski A, Baran M, Gumbarewicz E, Stepulak A
Cancers (Basel). 2025; 17(2).
PMID: 39858010
PMC: 11764116.
DOI: 10.3390/cancers17020228.
A five-plex Hepatic Oncochip reveals EMT triplet correlated with BAP31 in liver cancer.
Kong Y, Zhuang T, Ding X, Cai S, Ding W, Zhang X
Front Cell Dev Biol. 2025; 12():1478444.
PMID: 39834395
PMC: 11743502.
DOI: 10.3389/fcell.2024.1478444.
E-Cadherin-Mediated Cell-Cell Adhesion and Invasive Lobular Breast Cancer.
Bullock E, Brunton V
Adv Exp Med Biol. 2025; 1464():259-275.
PMID: 39821030
DOI: 10.1007/978-3-031-70875-6_14.
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.
Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E
J Hematol Oncol. 2025; 18(1):6.
PMID: 39806516
PMC: 11733683.
DOI: 10.1186/s13045-024-01634-6.
Synergistic Effects of Mistletoe Lectin and Cisplatin on Triple-Negative Breast Cancer Cells: Insights from 2D and 3D In Vitro Models.
Lyu S, Meshesha S, Hong C
Int J Mol Sci. 2025; 26(1.
PMID: 39796221
PMC: 11719730.
DOI: 10.3390/ijms26010366.
Vertex model with internal dissipation enables sustained flows.
Rozman J, Chaithanya K, Yeomans J, Sknepnek R
Nat Commun. 2025; 16(1):530.
PMID: 39789022
PMC: 11718050.
DOI: 10.1038/s41467-025-55820-2.
The Role of miR-486-5p on CSCs Phenotypes in Colorectal Cancer.
Etzi F, Grinan-Lison C, Fenu G, Gonzalez-Titos A, Pisano A, Farace C
Cancers (Basel). 2025; 16(24.
PMID: 39766136
PMC: 11674241.
DOI: 10.3390/cancers16244237.
